| Literature DB >> 31316336 |
Zhe Ding1,2, Mingbiao Ma1,2, Lvyan Tao1,3, Yun Peng1,2, Yuanyuan Han4, Luyun Sun1, Xiting Dai1,2, Zhenhua Ji1,2, Ruolan Bai1,3, Miaomiao Jian1,3, Taigui Chen1,2, Lisha Luo1,3, Feng Wang1, Yunfeng Bi1, Aihua Liu1,3,5,6, Fukai Bao1,2,5,6.
Abstract
Lyme neuroborreliosis (LNB) is the most dangerous manifestation of Lyme disease caused by the spirochete Borrelia burgdorferi which can reach the central nervous system most commonly presenting with lymphocytic meningitis; however, the molecular basis for neuroborreliosis is still poorly understood. We incubated explants from the frontal cortex of three rhesus brains with medium alone or medium with added live Borrelia burgdorferi for 6, 12, and 24 h and isolated RNA from each group was used for RNA sequencing with further bioinformatic analysis. Transcriptomic differences between the ex vivo model of live Borrelia burgdorferi with rhesus frontal cortex tissue explants and the controls during the progression of the infection were identified. A total of 2249, 1064, and 420 genes were significantly altered, of which 80.7, 52.9, and 19.8% were upregulated and 19.3, 47.1, 80.2% were downregulated at 6, 12, and 24 h, respectively. Gene ontology and KEGG pathway analyses revealed various pathways related to immune and inflammatory responses during the spirochete infection were enriched which is suggested to have a causal role in the pathogenesis of neurological Lyme disease. Moreover, we propose that the overexpressed FOLR2 which was demonstrated by the real-time PCR and western blotting could play a key role in neuroinflammation of the neuroborreliosis based on PPI analysis for the first time. To our knowledge, this is the first study to provide comprehensive information regarding the transcriptomic signatures that occur in the frontal cortex of the brain upon exposure to Borrelia burgdorferi, and suggest that FOLR2 is a promising target that is associated with neuroinflammation and may represent a new diagnostic or therapeutic marker in LNB.Entities:
Keywords: Borrelia burgdorferi; CNS; FOLR2; Lyme neuroborreliosis; innate immune system; neuroinflammation; transcriptomic analysis
Year: 2019 PMID: 31316336 PMCID: PMC6610209 DOI: 10.3389/fnins.2019.00651
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 4.677
FIGURE 1Schematic description of the experimental design. The asterisk represents the Borrelia burgdorferi spirochetes.
FIGURE 2Overview of mRNA profiling in this study. (A) Boxplot of the gene expression levels of various samples. Box charts for each region correspond to the maximum, upper quartile, median, lower quartile, and minimum of log10 (RPKM). (B) Scatter plot of the gene expression correlation in this study. The abscissa and ordinate represent log10(RPKM) of different sample genes respectively. (C–E) MA plot indicating upregulated and downregulated differentially expressed genes (DEGs) in the ex vivo model 6, 12, and 24 h after Bb infection. The abscissa represented Average log2 (CPM). The ordinate represented log2 (FC). The two blue lines represent the threshold of differentially expressed genes and the points outside the threshold are marked in red. log2 (FC) > 1 represents upregulated and log2 (FC) < -1 represents downregulated. (F) Venn diagram representing the overlap of identified DEGs. Overlaps showing 6 h-DEGs (n = 2249; yellow), 12 h-DEGs (n = 1064; red), 24 h-DEGs (n = 420; green), 6, 12, 24 h-DEGs (n = 3382; blue). (G) Number of upregulated and downregulated DEGs at 6, 12, and 24 h.
FIGURE 3Heatmap of DEGs identified by RNA sequencing showing the hierarchical clustering of the relative expression of a portion of the DEGs in each sample, for the sake of brevity. The Bb group and control group are represented by red and green, respectively. High and low abundance of gene expression are shown in red and blue, respectively.
FIGURE 4GO annotation analysis of upregulated and downregulated DEGs at various time points. GO annotation characterization of the molecular functions, biological processes, and cellular components based on significantly upregulated or downregulated DEGs. (A) GO annotation for upregulated DEGs at 6 h. (B) GO annotation for downregulated DEGs at 6 h. (C) GO annotation for upregulated DEGs at 12 h. (D) GO annotation for downregulated DEGs at 12 h. (E) GO annotation for upregulated DEGs at 24 h. (F) GO annotation for downregulated DEGs at 24 h.
FIGURE 5KEGG pathway enrichment analysis of upregulated and downregulated DEGs at various time points. The dot size and depth indicate the number of DEGs contained in the KEGG pathway and the degree of enrichment of the rich factor, respectively. We chose the most significant top 20 GO terms according to –log10 (P-value). (A–C) KEGG analysis of upregulated DEGs at 6, 12, and 24 h. (D–F) KEGG analysis of downregulated DEGs at 6, 12, and 24 h. Rich factor: the enrichment factor of KEGG pathway enrichment analysis of DEGs; Input number: the number of genes enriched in this pathway in the list of differentially expressed genes.
FIGURE 6The network analysis of the biological interactions within DEGs based on the RNA-seq datasets. (A) The PPI network of DEGs related to immune responses. The network nodes represent proteins and the edges represent protein-protein associations. The position of FOLR2 is marked by a red asterisk. (B) The network of DEGs related to immune responses using Cytoscape. The first neighbors of FOLR2 (red) were STAB1 (yellow) and C1QB (green). (C) Representative biological process based on BiNGO. (D) Representative cellular component based on BiNGO. (E) Representative molecular function based on BiNGO. Orange categories are most significantly overrepresented and white nodes are not significantly overrepresented. The area of a node was proportional to the number of DEGs in the test set.
KEGG pathways analysis in the PPI network.
| Pathway ID | Pathway description | Count in gene set | False discovery rate (FDR) | –LOG10(FDR) |
|---|---|---|---|---|
| 4610 | Complement and coagulation cascades | 12 | 3.49E-17 | 16.45717457 |
| 5150 | 8 | 8.34E-11 | 10.07883395 | |
| 4014 | Ras signaling pathway | 10 | 1.65E-08 | 7.78251606 |
| 4010 | MAPK signaling pathway | 10 | 4.67E-08 | 7.33068312 |
| 4015 | Rap1 signaling pathway | 9 | 9.93E-08 | 7.00305075 |
| 4640 | Hematopoietic cell lineage | 7 | 9.93E-08 | 7.00305075 |
| 4064 | NF-kappa B signaling pathway | 7 | 1.00E-07 | 7.00000000 |
| 5152 | Tuberculosis | 8 | 3.81E-07 | 6.41907502 |
| 5140 | Leishmaniasis | 6 | 6.78E-07 | 6.16877031 |
| 5205 | Proteoglycans in cancer | 8 | 2.11E-06 | 5.67571754 |
Ontological analysis.
| GO-ID | Description | Correction | |
|---|---|---|---|
| 9611 | Response to wounding | 2.25E-17 | 3.01E-14 |
| 2684 | Positive regulation of immune system process | 8.84E-15 | 5.92E-12 |
| 23052 | Signaling | 3.51E-12 | 1.57E-09 |
| 2682 | Regulation of immune system process | 8.19E-12 | 2.74E-09 |
| 48583 | Regulation of response to stimulus | 1.31E-11 | 3.50E-09 |
| 5886 | Plasma membrane | 6.42E-11 | 8.42E-09 |
| 5615 | Extracellular space | 5.28E-08 | 3.46E-06 |
| 9986 | Cell surface | 9.53E-08 | 4.16E-06 |
| 16020 | Membrane | 3.71E-07 | 1.07E-05 |
| 45121 | Membrane raft | 4.07E-07 | 1.07E-05 |
| 60089 | Molecular transducer activity | 2.86E-06 | 3.06E-04 |
| 4871 | Signal transducer activity | 2.86E-06 | 3.06E-04 |
| 1948 | Glycoprotein binding | 8.32E-06 | 4.67E-04 |
| 4872 | Receptor activity | 8.74E-06 | 4.67E-04 |
| 4716 | Receptor signaling protein tyrosine kinase activity | 1.33E-05 | 5.70E-04 |
FIGURE 7Significant alteration of FOLR2 expression during the progressions of Bb infection. (A) Heatmap showing the fold changes of DEGs based on RNA-seq datasets at three time points in the frontal cortex co-cultured with live Bb compared with the control. Upregulated and downregulated genes are shown in yellow and blue, respectively. (B) Real-time PCR analysis of FOLR2 expression comparing explants from the frontal cortex of rhesus brains co-cultured with live Bb with the controls at 6, 12, and 24 h. (C) Protein expression of FOLR2 in explants from the frontal cortex of rhesus brains co-cultured with live Bb and the controls at 6, 12, and 24 h, validated by western blotting. (D) Western blotting results using total protein loading in the stain-free gel as a loading control. ∗p < 0.05, ∗∗p < 0.01, Bb vs. Control, analyzed with an unpaired two-tail Student t-test. Data were expressed as the means ± SEM.